Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies
Sheila M. Fleming, Ashley N. Davis, Emily Simons
Topics & Concepts
Substantia nigraAlpha-synucleinPars compactaNeuroprotectionNeuroinflammationParkinson's diseaseNeuroscienceMedicineDopamineDopaminergicNeurodegenerationSynucleinopathiesInflammationDiseaseImmunologyBiologyPathologyParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms